Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

T-Cell Depleted Double UCB With Post Transplant IL-2 for Refractory Myeloid Leukemia

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT01464359
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:36:42.953869+00:00
Published At
2015-05-15T00:00:00+00:00
Record Updated At
2017-12-28
Results Posted At
2015-05-15
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Acute Myelogenous Leukemia", "Refractory Acute Myelogenous Leukemia"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2017-12-28"
protocolSection.identificationModule.nctId
"NCT01464359"
protocolSection.identificationModule.officialTitle
"T-Cell Depleted Double UCB With Post Transplant IL-2 for Refractory Myeloid Leukemia"
protocolSection.statusModule.overallStatus
"TERMINATED"
protocolSection.designModule.phases
["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2015-05-15"

Study condition terms

  • Acute Myelogenous Leukemia (protocolSection.conditionsModule.conditions)
  • Refractory Acute Myelogenous Leukemia (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.